Scarica l'app Stockscreener
3.90
4.00%
0.15
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.75
Aprire:
$3.78
Volume 24 ore:
38,040
Relative Volume:
1.36
Capitalizzazione di mercato:
$7.37M
Reddito:
$389.00K
Utile/perdita netta:
$-13.13M
Rapporto P/E:
-3.778
EPS:
-1.0323
Flusso di cassa netto:
$-11.90M
1 W Prestazione:
+0.52%
1M Prestazione:
-8.24%
6M Prestazione:
-4.88%
1 anno Prestazione:
-83.30%
Intervallo 1D:
$3.63
$3.96
Intervallo di 1 settimana:
$3.41
$3.96
Portata 52W:
$2.637
$23.80
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Nome
Collplant Biotechnologies Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare CLGN vs VRTX, REGN, MRNA, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
3.90 | 7.37M | 389.00K | -13.13M | -11.90M | -1.0323 |
VRTX
Vertex Pharmaceuticals Inc
|
521.03 | 132.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
816.10 | 84.02B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
207.97 | 83.03B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
882.48 | 55.50B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
366.06 | 41.41B | 5.76B | 514.49M | 1.10B | 4.4813 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-02-17 | Iniziato | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Borsa (CLGN) Ultime notizie
A 10% stockholder proposes selling 15,550 CollPlant (CLGN) shares. - Stock Titan
An equity-and-warrant offering has $0 left to sell at CollPlant (CLGN). - Stock Titan
Warrants for up to 1.48M shares accompany CollPlant (CLGN)'s completed financing - Stock Titan
Form 13D/A CollPlant Biotechnologies Ltd. For: 10 October By Investing.com - Investing.com South Africa
Form 13D/A CollPlant Biotechnologies Ltd. For: 10 October By Investing.com - Investing.com Nigeria
Form 13D/A CollPlant Biotechnologies Ltd. For: 10 October By Investing.com - Investing.com India
Form 13D/A CollPlant Biotechnologies Ltd. For: 10 October By Investing.com - Investing.com Canada
Laser-based supercomputing research is the main planned use of CollPlant (CLGN)'s placement proceeds. - Stock Titan
CollPlant Biotechnologies Ltd. announced that it expects to receive $3.699986 million in funding - marketscreener.com
CollPlant Biotechnologies Ltd. (CLGN) stock price, news, quote and history - Yahoo Finance Singapore
CollPlant announces $3.7 million private placement By Investing.com - Investing.com Nigeria
CollPlant Biotechnologies (CLGN) Announces $3.7M Private Placeme - GuruFocus
COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT - Morningstar
COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT - TradingView
CollPlant announces $3.7 million private placement - Investing.com
COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT - Yahoo Finance
A passive investor reports more than 5% of CollPlant (CLGN), with sole voting power. - Stock Titan
Share issuance lowered Ami Sagy’s stake in CollPlant (CLGN) without him selling shares. - Stock Titan
CollPlant Biotechnologies Q2 Results: Adj. EPS $(1.69) misses estimate - scanx.trade
First-half revenue fell to $181K at CollPlant (CLGN), while its net loss widened. - Stock Titan
COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Morningstar
Nasdaq confirms CollPlant (NASDAQ: CLGN) back over its $1 minimum bid - Stock Titan
CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement - tradingview.com
CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement - PR Newswire
CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement - finance.yahoo.com
CollPlant Launches BioFlex as Recombinant Collagen Broadens - openPR.com
CollPlant expands into photonic computing with LightSolver acquisition and investor webinar set for Sept 17. - Pluang
A new kind of computer uses light to calculate. LightSolver will explain it Sept. 17. - Stock Titan
CollPlant (NASDAQ: CLGN) gives CFO 510,372 RSUs with 5-year vesting - Stock Titan
COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION - marketscreener.com
CollPlant Adds LightSolver Founder to Board After Closing Photonic Computing Acquisition - TipRanks
CollPlant Biotechnologies LtdADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Biotech CollPlant (CLGN) extends into photonic computing with LightSolver board move - Stock Titan
CollPlant adds LightSolver CEO Dr. Ruti Ben Shl... - Pluang
A physicist who helped create light-based computing joins CollPlant's board - stocktitan.net
CollPlant Biotechnologies LtdADR Peer Comparison – Compare with Others - Value Research
CollPlant Finalizes LightSolver Acquisition with $5 Million Equity Investment - Kalkine Media
CollPlant (CLGN) moves into photonic computing with LightSolver acquisition - Stock Titan
CLGN Looks 14.7% Overvalued on GF Value™ - GuruFocus
collplant completes acquisition of lightsolver, entering the photonic computing sector - Fidelity Investments
COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR - Yahoo Finance
A company working on 3D-printed organs now owns a laser-powered computing business - Stock Titan
COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR - PR Newswire
CollPlant Biotechnologies acquires laser-based computing startup LightSolver - Data Center Dynamics
CollPlant to Implement 1-for-10 Reverse Stock Split - marketscreener.com
CLGN Looks 24.2% Overvalued on GF Value™ - GuruFocus
Reverse split ahead for CollPlant (NASDAQ: CLGN) to help keep its Nasdaq listing - Stock Titan
COLLPLANT ANNOUNCES REVERSE SHARE SPLIT - PR Newswire
CollPlant to acquire LightSolver in photonic computing deal - Engineering.com
Collplant Biotechnologies Ltd Azioni (CLGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.91%
2.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):